Cargando…
Modulation of Inflammatory Responses by Wnt/β-Catenin Signaling in Dendritic Cells: A Novel Immunotherapy Target for Autoimmunity and Cancer
The Wnt/β-catenin pathway is an evolutionarily conserved signaling pathway critical for several biological processes. An aberrant Wnt/β-catenin signaling is linked to several human diseases. Emerging studies have highlighted the regulatory role of the Wnt/β-catenin signaling pathway in normal physio...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081350/ https://www.ncbi.nlm.nih.gov/pubmed/27833613 http://dx.doi.org/10.3389/fimmu.2016.00460 |
_version_ | 1782462872184422400 |
---|---|
author | Suryawanshi, Amol Tadagavadi, Raghu K. Swafford, Daniel Manicassamy, Santhakumar |
author_facet | Suryawanshi, Amol Tadagavadi, Raghu K. Swafford, Daniel Manicassamy, Santhakumar |
author_sort | Suryawanshi, Amol |
collection | PubMed |
description | The Wnt/β-catenin pathway is an evolutionarily conserved signaling pathway critical for several biological processes. An aberrant Wnt/β-catenin signaling is linked to several human diseases. Emerging studies have highlighted the regulatory role of the Wnt/β-catenin signaling pathway in normal physiological processes of parenchymal and hematopoietic cells. Recent studies have shown that the activation of Wnt/β-catenin pathway in dendritic cells (DCs) play a critical role in mucosal tolerance and suppression of chronic autoimmune pathologies. Alternatively, tumors activate Wnt/β-catenin pathway in DCs to induce immune tolerance and thereby evade antitumor immunity through suppression of effector T cell responses and promotion of regulatory T cell responses. Here, we review our work and current understanding of how Wnt/β-catenin signaling in DCs shapes the immune response in cancer and autoimmunity and discuss how Wnt/β-catenin pathway can be targeted for successful therapeutic interventions in various human diseases. |
format | Online Article Text |
id | pubmed-5081350 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-50813502016-11-10 Modulation of Inflammatory Responses by Wnt/β-Catenin Signaling in Dendritic Cells: A Novel Immunotherapy Target for Autoimmunity and Cancer Suryawanshi, Amol Tadagavadi, Raghu K. Swafford, Daniel Manicassamy, Santhakumar Front Immunol Immunology The Wnt/β-catenin pathway is an evolutionarily conserved signaling pathway critical for several biological processes. An aberrant Wnt/β-catenin signaling is linked to several human diseases. Emerging studies have highlighted the regulatory role of the Wnt/β-catenin signaling pathway in normal physiological processes of parenchymal and hematopoietic cells. Recent studies have shown that the activation of Wnt/β-catenin pathway in dendritic cells (DCs) play a critical role in mucosal tolerance and suppression of chronic autoimmune pathologies. Alternatively, tumors activate Wnt/β-catenin pathway in DCs to induce immune tolerance and thereby evade antitumor immunity through suppression of effector T cell responses and promotion of regulatory T cell responses. Here, we review our work and current understanding of how Wnt/β-catenin signaling in DCs shapes the immune response in cancer and autoimmunity and discuss how Wnt/β-catenin pathway can be targeted for successful therapeutic interventions in various human diseases. Frontiers Media S.A. 2016-10-27 /pmc/articles/PMC5081350/ /pubmed/27833613 http://dx.doi.org/10.3389/fimmu.2016.00460 Text en Copyright © 2016 Suryawanshi, Tadagavadi, Swafford and Manicassamy. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Suryawanshi, Amol Tadagavadi, Raghu K. Swafford, Daniel Manicassamy, Santhakumar Modulation of Inflammatory Responses by Wnt/β-Catenin Signaling in Dendritic Cells: A Novel Immunotherapy Target for Autoimmunity and Cancer |
title | Modulation of Inflammatory Responses by Wnt/β-Catenin Signaling in Dendritic Cells: A Novel Immunotherapy Target for Autoimmunity and Cancer |
title_full | Modulation of Inflammatory Responses by Wnt/β-Catenin Signaling in Dendritic Cells: A Novel Immunotherapy Target for Autoimmunity and Cancer |
title_fullStr | Modulation of Inflammatory Responses by Wnt/β-Catenin Signaling in Dendritic Cells: A Novel Immunotherapy Target for Autoimmunity and Cancer |
title_full_unstemmed | Modulation of Inflammatory Responses by Wnt/β-Catenin Signaling in Dendritic Cells: A Novel Immunotherapy Target for Autoimmunity and Cancer |
title_short | Modulation of Inflammatory Responses by Wnt/β-Catenin Signaling in Dendritic Cells: A Novel Immunotherapy Target for Autoimmunity and Cancer |
title_sort | modulation of inflammatory responses by wnt/β-catenin signaling in dendritic cells: a novel immunotherapy target for autoimmunity and cancer |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081350/ https://www.ncbi.nlm.nih.gov/pubmed/27833613 http://dx.doi.org/10.3389/fimmu.2016.00460 |
work_keys_str_mv | AT suryawanshiamol modulationofinflammatoryresponsesbywntbcateninsignalingindendriticcellsanovelimmunotherapytargetforautoimmunityandcancer AT tadagavadiraghuk modulationofinflammatoryresponsesbywntbcateninsignalingindendriticcellsanovelimmunotherapytargetforautoimmunityandcancer AT swafforddaniel modulationofinflammatoryresponsesbywntbcateninsignalingindendriticcellsanovelimmunotherapytargetforautoimmunityandcancer AT manicassamysanthakumar modulationofinflammatoryresponsesbywntbcateninsignalingindendriticcellsanovelimmunotherapytargetforautoimmunityandcancer |